Safety, and Tolerability (DBCOND0150174)

Identifiers

Synonyms
Safety and Tolerability

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05469854
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan GlurateNo drug interventionsbasic_science1recruiting
NCT06453824
SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy ParticipantsNo drug interventionstreatment1recruiting
NCT03853421
Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparintreatment1completed
NCT05431634
Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy ParticipantsNo drug interventionstreatment1completed
NCT01952548
Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult VolunteersNo drug interventionsNot Available1completed
NCT02029482
Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy SubjectsNot Available1completed
NCT05223660
A Phase I Pharmacokinetics Study for KT07 CapsuleNo drug interventionshealth_services_research1completed
NCT06181760
A Study to Evaluate the Safety of Fenretinide in Healthy Volunteerstreatment1completed
NCT06000891
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570treatment1recruiting
NCT03307512
PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPDtreatment2terminated
NCT06331884
Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)No drug interventionstreatment1recruiting
NCT03809052
A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjectsother1completed
NCT05997641
Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy SubjectsNo drug interventionstreatment1active_not_recruiting
NCT06079541
Phase 1 Clinical Study of JMKX003142 TabletsNo drug interventionsbasic_science1recruiting
NCT01226316
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedulestreatment1active_not_recruiting
NCT05907382
Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy SubjectsNo drug interventionsbasic_science1recruiting
NCT03702231
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)basic_science2completed
NCT01692262
Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.screening1completed
NCT03046589
DP13 SAD & MAD in Healthy Male SubjectsNo drug interventionstreatment1completed
NCT05451667
Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteerstreatment1completed
NCT01907867
Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacintreatment1completed
NCT01895946
Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerabilitytreatment1completed
NCT03817346
Study of Ascending Single Oral Dose of GT-002 in Healthy VolunteersNo drug interventionsbasic_science1completed
NCT03685708
HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)prevention2completed